Alyeska Investment Group’s Gain Therapeutics GANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-450,000
Closed -$576K 586
2024
Q2
$576K Buy
+450,000
New +$576K ﹤0.01% 460